Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP645972.RA2bLpP_aMVax1F4ePDGoDdZfRNFqdz8aNOVsfFRBDN8s130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP645972.RA2bLpP_aMVax1F4ePDGoDdZfRNFqdz8aNOVsfFRBDN8s130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP645972.RA2bLpP_aMVax1F4ePDGoDdZfRNFqdz8aNOVsfFRBDN8s130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP645972.RA2bLpP_aMVax1F4ePDGoDdZfRNFqdz8aNOVsfFRBDN8s130_provenance.
- NP645972.RA2bLpP_aMVax1F4ePDGoDdZfRNFqdz8aNOVsfFRBDN8s130_assertion description "[Furthermore, recently identified ERK1/2-inducing mutations in MEK1 and MEK2 (MEK1/2) MAPK genes in melanoma confer resistance to emerging therapeutic MEK inhibitors, underscoring the challenges facing direct kinase inhibition in cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645972.RA2bLpP_aMVax1F4ePDGoDdZfRNFqdz8aNOVsfFRBDN8s130_provenance.
- NP645972.RA2bLpP_aMVax1F4ePDGoDdZfRNFqdz8aNOVsfFRBDN8s130_assertion evidence source_evidence_literature NP645972.RA2bLpP_aMVax1F4ePDGoDdZfRNFqdz8aNOVsfFRBDN8s130_provenance.
- NP645972.RA2bLpP_aMVax1F4ePDGoDdZfRNFqdz8aNOVsfFRBDN8s130_assertion SIO_000772 23603816 NP645972.RA2bLpP_aMVax1F4ePDGoDdZfRNFqdz8aNOVsfFRBDN8s130_provenance.
- NP645972.RA2bLpP_aMVax1F4ePDGoDdZfRNFqdz8aNOVsfFRBDN8s130_assertion wasDerivedFrom befree-20150227 NP645972.RA2bLpP_aMVax1F4ePDGoDdZfRNFqdz8aNOVsfFRBDN8s130_provenance.
- NP645972.RA2bLpP_aMVax1F4ePDGoDdZfRNFqdz8aNOVsfFRBDN8s130_assertion wasGeneratedBy ECO_0000203 NP645972.RA2bLpP_aMVax1F4ePDGoDdZfRNFqdz8aNOVsfFRBDN8s130_provenance.
- befree-20150227 importedOn "2015-02-27" NP645972.RA2bLpP_aMVax1F4ePDGoDdZfRNFqdz8aNOVsfFRBDN8s130_provenance.